Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Cancer Research
|
December 1, 1984
Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines
D S Groveman, E C Borden, J A Merritt, et al.
Clinical and Experimental Immunology
|
July 1, 1987
Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon
G T Spear, D M Paulnock, R L Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m
W D Quan, G E Dean, L Spears, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans
M J Hawkins, E C Borden, J A Merritt, et al.
Cytometry
|
October 12, 1999
Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy
J W Jacobberger, R M Sramkoski, D Zhang, et al.
AIDS Research and Human Retroviruses
|
September 1, 1991
Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients
T W Pitts, M J Bohanon, M F Leach, et al.
The Journal of Urology
|
January 1, 1992
Phase 1 trial of oral bropirimine in superficial bladder cancer
M F Sarosdy, D L Lamm, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma
G L Clayman, A K el-Naggar, S M Lippman, et al.
Seminars in Oncology
|
August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement
J A Roth, S G Swisher, J A Merritt, et al.
Cancer Gene Therapy
|
May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)
N Yen, C G Ioannides, K Xu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Cancer Research
|
December 1, 1984
Augmented antiproliferative effects of interferons at elevated temperatures against human bladder carcinoma cell lines
D S Groveman, E C Borden, J A Merritt, et al.
Clinical and Experimental Immunology
|
July 1, 1987
Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon
G T Spear, D M Paulnock, R L Jordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m
W D Quan, G E Dean, L Spears, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1984
Comparison of the biologic effects of two recombinant human interferons alpha (rA and rD) in humans
M J Hawkins, E C Borden, J A Merritt, et al.
Cytometry
|
October 12, 1999
Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy
J W Jacobberger, R M Sramkoski, D Zhang, et al.
AIDS Research and Human Retroviruses
|
September 1, 1991
Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients
T W Pitts, M J Bohanon, M F Leach, et al.
The Journal of Urology
|
January 1, 1992
Phase 1 trial of oral bropirimine in superficial bladder cancer
M F Sarosdy, D L Lamm, R D Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma
G L Clayman, A K el-Naggar, S M Lippman, et al.
Seminars in Oncology
|
August 15, 1998
Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement
J A Roth, S G Swisher, J A Merritt, et al.
Cancer Gene Therapy
|
May 16, 2000
Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53)
N Yen, C G Ioannides, K Xu, et al.
Page
of 4